Takeda Pharmaceuticals announced that it will incur restructuring expenses of 140 billion yen in the 2024 fiscal year
海角七号
发表于 2024-5-9 16:02:58
222
0
0
Takeda Pharmaceuticals stated that as part of its multi-year plan to support growth and improve profit margins, the company will incur a one-time restructuring fee of 140 billion yen in the 2024 fiscal year, which has been reflected in the full year forecast. Takeda Pharmaceuticals stated that it will include measures to optimize its workforce, and specific details will be provided in& Quota; At the appropriate time& Quota; Decision. (Bloomberg)
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Tesla raises full year capital expenditure forecast for 2024
- Continuing to target lower tier cities, Starbucks China enters 166 county-level markets in fiscal year 2024
- Nomura Holdings' second quarter net profit of 98.39 billion yen
- Infineon: Revenue for fiscal year 2024 decreased by 8% year-on-year
- Revenue growth of 5% in the second quarter of fiscal year 2025, Taobao's "Double 11" victory, Alibaba's confidence in the future has returned
- Honeywell lowers its performance expectations for this fiscal year and reaches a settlement with Bombardier over engine litigation
- Nearly 2.3 billion in sales expenses, resulting in a loss of 900 million! Where is the 'money path' of Gaotu?
- Broadcom's US stock market rose nearly 14% before trading, with Q4 profits exceeding expectations and AI revenue doubling by 220% for the entire fiscal year
- Honda Nissan Joint Statement: Target to achieve overall annual sales of over 30 trillion yen and annual operating profit of over 3 trillion yen after the merger
- Planning to purchase AI chips for 7 billion US dollars? ByteDance or leading a new round of capital expenditure wave
